Centogene stock rises on extending diagnostic pact with Takeda

Centogene (CNTG) said it extended its collaboration with Takeda (TAK) to diagnose patients with Lysosomal Storage Disorders. Read more here.

Related Keywords

Ian Rentsch ,Michael Vi ,Shire Pharmaceuticals ,Takeda Pharmaceutical ,Stock Editorial ,Lysosomal Storage Disorders ,Chief Commercial Officer ,General Manager Ian ,